Serum multivalent cationic pattern: Speculation on the efficient approach for detection of Alzheimer's disease

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Azhdarzadeh, Morteza ^a   Noroozian, Maryam ^b   Aghaverdi, Haniyeh ^c   Akbari, Seyed Mostafa ^d   Baum, Larry ^a,e   Mahmoudi, Morteza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COPPER; IRON; ZINC;

ALZHEIMER DISEASE; BLOOD; CASE CONTROL STUDY; CHINA; CLUSTER ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; IRAN; MALE; MASS SPECTROMETRY; PRINCIPAL COMPONENT ANALYSIS;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; CLUSTER ANALYSIS; COPPER; FEMALE; HUMANS; IRAN; IRON; MALE; MASS SPECTROMETRY; PRINCIPAL COMPONENT ANALYSIS; ZINC;

EID: 84944174559     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02782     Document Type: Article

References (44)

1. Brookmeyer, R. et al. National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement. 7, 61-73 (2011)
2. Jack Jr, C. R. et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128 (2010)
3. Jicha, G. A. et al. Preclinical AD Workgroup staging: Pathological correlates and potential challenges. Neurobiol. Aging 33, 622.e621-622.e616 (2012)
4. Price, J. L. &Morris, J. C. Tangles and plaques in nondemented aging and ;preclinical' alzheimer's disease. Ann. Neurol. 45, 358-368 (1999)
5. Schmitt, F. A. et al. ;Preclinical' AD revisited: Neuropathology of cognitively normal older adults. Neurology 55, 370-376 (2000)
6. Braak, H. &Braak, E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357 (1997)
7. Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New Engl. J. Med. 367, 795-804 (2012)
8. Bateman, R. J. et al. Autosomal-dominant Alzheimer's disease: A review and proposal for the prevention of Alzheimer's disease. Alzheimers Res. Ther. 2, (2011)
9. Laurent, S., Ejtehadi, M. R., Rezaei, M., Kehoe, P. G. &Mahmoudi, M. Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease. RSC Adv. 2, 5008-5033 (2012)
10. Cohen, F. E.&Kelly, J. W. Therapeutic approaches to protein-misfolding diseases. Nature 426, 905-909 (2003)
11. Dobson, C. M. Protein folding and misfolding. Nature 426, 884-890 (2003)
12. Stefani, M. &Dobson, C. M. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81, 678-699 (2003)
13. Bush, A. I. et al. Rapid induction of Alzheimer Ab amyloid formation by zinc. Science 265, 1464-1467 (1994)
14. Adlard, P. A., Manso, Y., Comes, G., Hidalgo, J. &Bush, A. I. Copper modulation as a therapy for Alzheimer's disease? Int. J. Alzheimers Dis. (2011)
15. Duce, J. A., Bush, A. I. &Adlard, P. A. Role of amyloid-b-metal interactions in Alzheimers disease. Future Neurol. 6, 641-659 (2011)
16. Kaden, D., Bush, A. I., Danzeisen, R., Bayer, T. A. &Multhaup, G. Disturbed copper bioavailability in Alzheimer's disease. Int. J. Alzheimers Dis. 370345 (2011)
17. Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L. &Duce, J. A. The role of metallobiology and amyloid-b peptides in Alzheimer's disease. J. Neurochem. 120, 149-166 (2012)
18. Sensi, S. L. et al. The neurophysiology and pathology of brain zinc. J. Neurosci. 31, 16076-16085 (2011)
19. Al-Torres, J., Rodrguez-Santiago, L.&Sodupe, M. Computational calculations of pK a values of imidazole in Cu(ii) complexes of biological relevance. Phys. Chem. Chem. Phys. 13, 7852-7861 (2011)
20. Bush, A. I. The metal theory of Alzheimer's disease. J. Alzheimers Dis. 33, S277-S281 (2013)
21. McMaster, D. et al. Serum copper and zinc in random samples of the population of Northern Ireland. Am. J. Clinical Nut. 56, 440-446 (1992)
22. Bucossi, S. et al. Copper in Alzheimer's disease: a meta-Analysis of serum, plasma, and cerebrospinal fluid studies. J. Alzheimers Dis. 24, 175-185 (2011)
23. ROSSP, L., Squitti, R., Calabrese, L., Rotilio, G. &Rossini, P. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy. J. Nut. Health Aging 11, 408-417 (2007)
24. Baum, L. et al. Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals 23, 173-179 (2010)
25. Brewer, G. J. et al. Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease. Am. J. Alzheimers Dis. Dement. 25, 572-575 (2010)
26. Smorgon, C. et al. Trace elements and cognitive impairment: an elderly cohort study. Arch. Gerontol. Geriatr. 393-402 (2004)
27. Strozyk, D. et al. Zinc and copper modulate Alzheimer Ab levels in human cerebrospinal fluid. Neurobiol. Aging 30, 1069-1077 (2009)
28. Ahluwalia, N. et al. Iron status and stores decline with age in Lewis rats. J. Nut. 130, 2378-2383 (2000)
29. Gerhardsson, L., Lundh, T., Londos, E. &Minthon, L. Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease. J. Neural Transm. 118, 957-962 (2011)
30. Gerhardsson, L., Lundh, T., Minthon, L. &Londos, E. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 25, 508-515 (2008)
31. Menden, E. E., Elia, V. J., Michael, L. W. &Petering, H. G. Distribution of cadmium and nickel of tobacco during cigarette smoking. Environ. Sci. Technol. 6, 830-832 (1972)
32. Walton, J. Aluminum disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer's disease. J. Alzheimers Dis. 29, 255-273 (2012)
33. Afrin, L. B. Fatal copper deficiency from excessive use of zinc-based denture adhesive. Am. J. Med. Sci. 340, 164-168 (2010)
34. Willis, M. S. et al. Zinc-induced copper deficiency: A report of three cases initially recognized on bone marrow examination. Am. J. Clinical Pathol. 123, 125-131 (2005)
35. Choi, J. W. &Kim, S. K. Relationships of lead, copper, zinc, and cadmium levels versus hematopoiesis and iron parameters in healthy adolescents. Ann. Clinical Lab. Sci. 35, 428-434 (2005)
36. Thevenod, F. Catch me if you can! Novel aspects of cadmium transport in mammalian cells. Biometals 23, 857-875 (2010)
37. Vesey, D. A. Transport pathways for cadmium in the intestine and kidney proximal tubule: focus on the interaction with essential metals. Toxicol. lett. 198, 13-19 (2010)
38. Martelli, A., Rousselet, E., Dycke, C., Bouron, A. &Moulis, J.-M. Cadmium toxicity in animal cells by interference with essential metals. Biochimie 88, 1807-1814 (2006)
39. Woolfson, J. P. Examination of Cadmium-Induced Heat Shock Protein Gene Expression in Xenopus laevis A6 Kidney Epithelial Cells. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 152, 91-99 (2009)
40. Mah, V. &Jalilehvand, F. Cadmium (II) complex formation with glutathione. JBIC J. Biol. Inorg. Chem. 15, 441-458 (2010)
41. Potocki, S. et al. Metal Transport and Homeostasis within the Human Body: Toxicity Associated with Transport Abnormalities. Curr. Med. Chem. 19, 2738-2759 (2012)
42. Doecke Jd, L. S. M. F. N. G. et al. BLood-based protein biomarkers for diagnosis of alzheimer disease. Arch. Neurol. 69, 1318-1325 (2012)
43. Isaacs, B., Kennie, A. The Set Test as an aid to the detection of dementia in old people. Br. J. Psychiatry 123, 467-470 (1973)
44. Sclan, S. G., Reisberg, B. Functional Assessment Staging (FAST) in Alzheimer's Disease: Reliability, Validity, and Ordinality. nternational Psychogeriatrics 4, 55-69 (1992)